List view / Grid view
The FDA have granted a first of its kind indication…
The FDA have granted a first of its kind indication for Xywav for the treatment of idiopathic hypersomnia (IH) in adults.
The FDA conditionally approved Sarepta’s Amondys 45 (casimersen) after interim…
The FDA conditionally approved Sarepta’s Amondys 45 (casimersen) after interim Phase III results indicated the treatment is reasonably likely to be of clinical benefit.
The FDA has approved Aimovig for the preventive treatment of…
The FDA has approved Aimovig for the preventive treatment of a migraine in adults. The treatment is given by once-monthly self-injections...
